Marshall Wace, LLP Sarepta Therapeutics, Inc. Transaction History

Marshall Wace, LLP

  • $63.3 Billion
  • Q1 2024

A detailed history of Marshall Wace, LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 3,343 shares of SRPT stock, worth $507,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,343
Holding current value
$507,233
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$93.7 - $141.53 $313,239 - $473,134
3,343 New
3,343 $432,000
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $19.2 Million - $23.1 Million
186,886 Added 316.53%
245,928 $29.8 Million
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $12.8 Million - $18.9 Million
-120,217 Reduced 67.06%
59,042 $6.76 Million
Q1 2023

May 15, 2023
SELL
$117.53 - $155.99 $792,857 - $1.05 Million
-6,746 Reduced 3.63%
179,259 $24.7 Million
Q4 2022

Feb 14, 2023
BUY
$100.86 - $132.13 $18.8 Million - $24.6 Million
186,005 New
186,005 $24.1 Million
Q1 2022

May 16, 2022
SELL
$63.15 - $90.42 $31.8 Million - $45.5 Million
-503,638 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $38.7 Million - $49.7 Million
500,289 Added 14938.46%
503,638 $45.4 Million
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $1.07 Million - $1.5 Million
-16,170 Reduced 82.84%
3,349 $310,000
Q2 2021

Aug 13, 2021
SELL
$69.38 - $86.75 $250,947 - $313,774
-3,617 Reduced 15.63%
19,519 $1.52 Million
Q1 2021

May 17, 2021
BUY
$72.25 - $168.95 $1.67 Million - $3.91 Million
23,136 New
23,136 $1.73 Million
Q4 2019

Feb 14, 2020
SELL
$76.53 - $135.58 $1.85 Million - $3.27 Million
-24,153 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$72.81 - $156.91 $1.76 Million - $3.79 Million
24,153 New
24,153 $1.82 Million
Q2 2019

Aug 14, 2019
SELL
$112.21 - $151.95 $669,557 - $906,685
-5,967 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$106.67 - $151.68 $473,508 - $673,307
-4,439 Reduced 42.66%
5,967 $711,000
Q4 2018

Feb 14, 2019
BUY
$97.32 - $148.76 $1.01 Million - $1.55 Million
10,406 New
10,406 $1.14 Million
Q3 2018

Nov 14, 2018
SELL
$115.31 - $161.51 $422,841 - $592,257
-3,667 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$71.74 - $153.69 $309,988 - $664,094
-4,321 Reduced 54.09%
3,667 $485,000
Q1 2018

May 15, 2018
BUY
$54.02 - $82.27 $99,666 - $151,788
1,845 Added 30.03%
7,988 $592,000
Q4 2017

Feb 14, 2018
SELL
$47.64 - $56.75 $1.03 Million - $1.23 Million
-21,670 Reduced 77.91%
6,143 $342,000
Q3 2017

Nov 13, 2017
BUY
$35.73 - $47.15 $993,758 - $1.31 Million
27,813
27,813 $1.25 Million

Others Institutions Holding SRPT

# of Institutions
470
Shares Held
79.3M
Call Options Held
4.23M
Put Options Held
1.21M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.3B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email